Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

67.85
Delayed Data
As of 4:00pm ET
 +0.66 / +0.98%
Today’s Change
64.18
Today|||52-Week Range
87.21
-19.48%
Year-to-Date
Better Buy: Eli Lilly and Company vs. AbbVie
12:08pm / MotleyFool.com - Paid Partner Content
5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
Dec 08 / Zacks.com - Paid Partner Content
Jim Cramer -- Be Careful With Biogen; Apple Is Waking Up
10:47am / TheStreet.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Eli Lilly
Dec 07 / MotleyFool.com - Paid Partner Content
Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results
10:47am / TheStreet.com - Paid Partner Content
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
Dec 07 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs
9:08am / Zacks.com - Paid Partner Content
Lilly: Jardiance Label to Add Cardiovascular Indication
Dec 06 / Zacks.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly
8:14am / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Amazon, Dow Chemical, Ford, Eli Lilly and Eni
Dec 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close67.19
Today’s open67.38
Day’s range67.22 - 68.17
Volume4,350,639
Average volume (3 months)4,767,944
Market cap$74.2B
Dividend yield3.01%
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+2.64%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+1.75%
P/E ratio29.5
Price/Sales4.50
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+3.78+2.01%
NVONovo Nordisk+1.08+3.09%
AZNAstraZeneca+0.89+3.39%
CELGCelgene+0.41+0.36%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.96
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts


Search for Jobs